文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

危重症患者气管插管预氧合策略:随机试验的系统评价与网络Meta分析

Preoxygenation strategies for intubation of patients who are critically ill: a systematic review and network meta-analysis of randomised trials.
PubMed 文献 · Lancet Respir Med · 2025-03-21
一句话结论网络Meta分析提示,危重症成人插管前用NIPPV或HFNC预氧合可能比面罩氧减少插管期低氧血症,NIPPV可能优于HFNC。

该系统评价与网络Meta分析检索Embase、MEDLINE、Web of Science、Scopus和Cochrane Central Register of Controlled Trials自建库至2024年10月31日的随机对照试验,纳入15项研究、3420例在ICU或急诊科需要插管的成人危重症患者。结果显示,NIPPV较HFNC可能降低插管期低氧血症发生率(RR 0.73,95%CI 0.55-0.98;p=0.032;中等确定性),NIPPV较面罩氧降低低氧血症(RR 0.51,95%CI 0.39-0.65;p<0.0001;高确定性),HFNC较面罩氧降低低氧血症(RR 0.69,95%CI 0.54-0.88;p=0.0064;高确定性)。各策略对首次插管成功率(均为低确定性)和全因死亡率(极低至中等确定性)似乎无影响。NIPPV较面罩氧可能降低严重不良事件风险(RR 0.30,95%CI 0.12-0.77;p=0.011;中等确定性),较HFNC可能降低严重不良事件风险(RR 0.32,95%CI 0.11-0.91;p=0.035;低确定性);HFNC较面罩氧可能不降低严重不良事件风险(RR 0.95,95%CI 0.60-1.51;p=0.83;低确定性)。

要点

  • NIPPV预氧合较面罩氧降低插管期低氧血症(RR 0.51,95%CI 0.39-0.65;p<0.0001;高确定性)。
  • NIPPV预氧合较HFNC可能降低插管期低氧血症(RR 0.73,95%CI 0.55-0.98;p=0.032;中等确定性)。
  • HFNC预氧合较面罩氧降低插管期低氧血症(RR 0.69,95%CI 0.54-0.88;p=0.0064;高确定性)。
  • NIPPV较面罩氧可能降低严重不良事件风险(RR 0.30,95%CI 0.12-0.77;p=0.011;中等确定性),较HFNC可能降低严重不良事件风险(RR 0.32,95%CI 0.11-0.91;p=0.035;低确定性)。
  • 各预氧合策略对首次插管成功率(均为低确定性)和全因死亡率(极低至中等确定性)似乎无影响。

适用人群与场景

  • 成人(年龄≥18岁)危重症需要气管插管、在重症监护室或急诊科环境中接受预氧合的患者。

研究设计与关键结果

  • 研究类型:系统评价与网络Meta分析,纳入15项随机对照试验,共3420例患者。
  • NIPPV预氧合较HFNC降低插管期低氧血症发生率(RR 0.73,95%CI 0.55-0.98;p=0.032;中等确定性)。
  • NIPPV预氧合较面罩氧降低插管期低氧血症发生率(RR 0.51,95%CI 0.39-0.65;p<0.0001;高确定性)。
  • HFNC预氧合较面罩氧降低插管期低氧血症发生率(RR 0.69,95%CI 0.54-0.88;p=0.0064;高确定性)。
  • 各预氧合策略对首次插管成功率均无影响(均为低确定性)。
  • 各预氧合策略对全因死亡率似乎均无影响(极低至中等确定性)。
  • NIPPV较面罩氧可能降低严重不良事件风险(RR 0.30,95%CI 0.12-0.77;p=0.011;中等确定性)。
  • NIPPV较HFNC可能降低严重不良事件风险(RR 0.32,95%CI 0.11-0.91;p=0.035;低确定性);HFNC较面罩氧可能不降低严重不良事件风险(RR 0.95,95%CI 0.60-1.51;p=0.83;低确定性)。

证据类型、等级与局限

  • 证据类型:系统评价与网络Meta分析(随机对照试验)。
  • 证据确定性采用GRADE方法评估:NIPPV vs HFNC低氧血症为中等确定性;NIPPV vs 面罩氧低氧血症为高确定性;HFNC vs 面罩氧低氧血症为高确定性;首次插管成功率均为低确定性;全因死亡率为极低至中等确定性;NIPPV vs 面罩氧严重不良事件为中等确定性;NIPPV vs HFNC严重不良事件为低确定性;HFNC vs 面罩氧严重不良事件为低确定性。
  • 偏倚风险采用改良Cochrane工具(RoB 2.0)评估。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对成人危重症患者气管插管前采用NIPPV或HFNC而非面罩氧预氧合,可能预防插管期低氧血症。
  • 作者认为,与HFNC相比,NIPPV可能降低插管期低氧血症发生率。
  • 作者认为,该研究结果将为更新的国际预氧合指南提供信息。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Preoxygenation is a crucial preparatory step for intubation. Several strategies for preoxygenation exist, including facemask oxygen, high-flow nasal cannula (HFNC), and non-invasive positive pressure ventilation (NIPPV). However, the comparative efficacy of these strategies remains largely uncertain. We aimed to compare the efficacy and safety of HFNC, NIPPV, and facemask oxygen for preoxygenation of patients who are critically ill requiring tracheal intubation.

METHODS: In this systematic review and network meta-analysis, we searched Embase, MEDLINE, Web of Science, Scopus, and Cochrane Central Register of Controlled Trials for randomised clinical trials published from database inception until Oct 31, 2024, with no language restrictions. We included randomised controlled trials that compared HFNC versus NIPPV, HFNC versus facemask oxygen, or NIPPV versus facemask oxygen in adult patients (age ≥18 years) who were critically ill requiring intubation in the intensive care or emergency department setting. We had no additional eligibility criteria for our network meta-analysis. We used Covidence software to screen eligible trials. Two reviewers independently screened trials for titles and abstracts, and then subsequently screened full-text reports. Discrepancies were resolved by discussion or a third party adjudicator. Summary-level data were extracted manually using a structured data collection form. Outcomes of interest were hypoxaemia during intubation, successful intubation on the first attempt, serious adverse events, and all-cause mortality. We performed a frequentist random-effects network meta-analysis. We assessed the risk of bias using the modified Cochrane tool (RoB 2.0) and the certainty of evidence using the GRADE approach. The protocol is registered on the Open Science Framework.

FINDINGS: We initially identified 6900 records, of which 48 were assessed via full-text screening, and 15 eligible studies with 3420 patients were included in our systematic review and network meta-analysis. Findings suggested that use of NIPPV for preoxygenation probably reduces the incidence of hypoxaemia during intubation versus HFNC (relative risk 0·73 [95% CI 0·55-0·98]; p=0·032; moderate certainty) and reduces the incidence of hypoxaemia versus facemask oxygen (0·51 [0·39-0·65]; p<0·0001; high certainty). HFNC for preoxygenation reduces the incidence of hypoxaemia during intubation versus facemask oxygen (0·69 [0·54-0·88]; p=0·0064; high certainty). None of the preoxygenation strategies affected the incidence of successful intubation on the first attempt (all low certainty). None of the preoxygenation strategies appeared to affect all-cause mortality (very low-to-moderate certainty). NIPPV probably reduces the risk of serious adverse events versus facemask oxygen (0·30 [0·12-0·77]; p=0·011; moderate certainty) and might reduce the risk of serious adverse events versus HFNC (0·32 [0·11-0·91]; p=0·035; low certainty). HFNC might not reduce the risk of serious adverse events versus facemask oxygen (0·95 [0·60-1·51]; p=0·83; low certainty).

INTERPRETATION: Preoxygenation with NIPPV or HFNC rather than facemask oxygen might prevent hypoxaemia during tracheal intubation of adults who are critically ill. Compared with HFNC, NIPPV probably decreases the incidence of hypoxaemia during intubation. Our findings will inform updated international guidelines on preoxygenation.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Pitre T, Liu W, Zeraatkar D, et al. Preoxygenation strategies for intubation of patients who are critically ill: a systematic review and network meta-analysis of randomised trials. Lancet Respir Med. 2025. PMID: 40127663. doi:10.1016/S2213-2600(25)00029-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。